Tsutomu Sasaki Selected Research

Tsutomu Sasaki Research Topics

Disease

23	Stroke (Strokes) 03/2024 - 08/2004
22	Ischemic Stroke 03/2024 - 04/2005
20	Ischemia 01/2019 - 02/2002
16	Obesity 12/2022 - 01/2010
12	Neoplasms (Cancer) 01/2024 - 07/2002
12	Infarction (Infarctions) 12/2021 - 02/2004
9	Brain Ischemia (Cerebral Ischemia) 12/2016 - 04/2002
8	Insulin Resistance 12/2022 - 06/2010
7	Body Weight (Weight, Body) 12/2022 - 01/2010
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2018 - 08/2004
5	Inflammation (Inflammations) 01/2023 - 05/2003
5	Hyperphagia (Overeating) 12/2022 - 01/2010
4	Thrombosis (Thrombus) 01/2023 - 12/2018
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 08/2012
3	Glucose Intolerance 01/2022 - 03/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2017 - 01/2008
3	Weight Gain 01/2015 - 04/2014
3	Hypertension (High Blood Pressure) 04/2014 - 10/2010
2	Hemorrhage 03/2024 - 12/2018
2	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2023
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 06/2017
2	Thrombocytopenia (Thrombopenia) 09/2022 - 01/2017
2	Hypothyroidism 01/2022 - 04/2012
2	Intracranial Embolism 01/2022 - 06/2017
2	Hypoxia (Hypoxemia) 12/2021 - 12/2018
2	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2008
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 01/2017
2	Neuroinflammatory Diseases 01/2019 - 01/2018
2	Hyperglycemia 01/2015 - 01/2013
2	Thinness 10/2014 - 07/2011
2	Cerebral Infarction 07/2009 - 06/2002
2	Meningioma (Meningiomas) 10/2008 - 07/2002
2	Central Nervous System Neoplasms 07/2002 - 01/2002
2	Nervous System Neoplasms (Neoplasms, Nervous System) 07/2002 - 01/2002
1	Acute Coronary Syndrome 03/2024
1	Embolism (Embolus) 03/2024
1	Myocardial Infarction 03/2024

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2002
7	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 08/2010
7	Sirtuin 1IBA 01/2022 - 01/2008
6	Insulin (Novolin)FDA Link 01/2020 - 02/2012
5	fibrin fragment D (D-dimer)IBA 01/2024 - 04/2016
5	Neuroprotective AgentsIBA 12/2022 - 04/2002
5	LeptinIBA 01/2015 - 04/2014
4	Protein Isoforms (Isoforms)IBA 11/2023 - 05/2005
4	Glutamic Acid (Glutamate)FDA Link 01/2019 - 04/2002
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2016 - 08/2010
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2013 - 08/2007
3	CytokinesIBA 01/2023 - 04/2014
3	Heparin (Liquaemin)FDA LinkGeneric 09/2022 - 04/2005
3	Thyroid HormonesIBA 01/2022 - 04/2012
3	NAD (NADH)IBA 01/2018 - 04/2014
3	Oxygen (Dioxygen)IBA 12/2016 - 08/2010
3	Bromodeoxyuridine (BrdU)IBA 05/2007 - 03/2002
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2021
2	Messenger RNA (mRNA)IBA 09/2023 - 01/2019
2	RNA (Ribonucleic Acid)IBA 09/2023 - 10/2008
2	MicroRNAs (MicroRNA)IBA 09/2023 - 12/2021
2	Evans Blue (Blue, Evans)FDA Link 01/2023 - 12/2020
2	Serine (L-Serine)FDA Link 12/2022 - 09/2015
2	Histones (Histone)IBA 01/2022 - 01/2017
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021 - 01/2016
2	EnzymesIBA 10/2020 - 07/2011
2	LipidsIBA 10/2020 - 09/2014
2	Leukotriene B4IBA 10/2020 - 01/2020
2	Peptides (Polypeptides)IBA 04/2020 - 04/2014
2	Corn Oil (Oil, Corn)IBA 01/2019 - 11/2018
2	Histone Deacetylase InhibitorsIBA 01/2018 - 01/2017
2	necdinIBA 01/2017 - 04/2012
2	miglitol (Glyset)FDA Link 01/2015 - 01/2013
2	Glycoside Hydrolase InhibitorsIBA 01/2015 - 01/2013
2	CarbohydratesIBA 01/2015 - 01/2013
2	N-Methylaspartate (NMDA)IBA 12/2014 - 08/2010
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2014 - 04/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2014 - 03/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2011 - 06/2008
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2011 - 12/2010
2	Antihypertensive Agents (Antihypertensives)IBA 01/2011 - 10/2010
2	rho-Associated KinasesIBA 07/2009 - 08/2007
2	salicylhydroxamic acid (SHAM)IBA 11/2006 - 03/2002
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2004 - 05/2003
2	ParaffinIBA 07/2002 - 01/2002
2	Formaldehyde (Formol)FDA Link 07/2002 - 01/2002
2	Apolipoproteins E (ApoE)IBA 04/2002 - 02/2002
2	ApolipoproteinsIBA 04/2002 - 02/2002
1	AnticoagulantsIBA 03/2024
1	apixabanIBA 03/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	AntigensIBA 01/2024
1	von Willebrand FactorIBA 01/2024
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2023
1	CateninsIBA 01/2023
1	Dextrans (Dextran)FDA Link 01/2023

Therapy/Procedure

7	Therapeutics 11/2023 - 08/2017
4	Drug Therapy (Chemotherapy) 01/2021 - 04/2016
3	Thrombectomy 01/2022 - 11/2020
3	Oral Administration 04/2016 - 07/2009
1	Drug Tapering 03/2024